ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Toshio Onitsuka
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuzaki, Y.
Right arrow Articles by Onitsuka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuzaki, Y.
Right arrow Articles by Onitsuka, T.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2004;78:1769-1772
© 2004 The Society of Thoracic Surgeons

Original article: general thoracic

Intrapleural Hyperthermic Perfusion With Chemotherapy Increases Apoptosis in Malignant Pleuritis

Yasunori Matsuzaki, MD, PhDa,*, Masao Edagawa, MD, PhDa, Tetsuya Shimizu, MD, PhDa, Masaki Hara, MD, PhDa, Masaki Tomita, MD, PhDa, Takanori Ayabe, MD, PhDa, Toshio Onitsuka, MD, PhDa

a Department of Surgery II, Miyazaki Medical College, University of Miyazaki, Miyazaki, Japan

Accepted for publication May 6, 2004.

* Address reprint requests to Dr Matsuzaki, Department of Surgery II, Miyazaki Medical College, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki, 889–1692, Japan
yasu{at}med.miyazaki-u.ac.jp

BACKGROUND: Previously, we reported on the effectiveness of intrapleural hyperthermic perfusion with chemotherapy, a new treatment we developed for patients with malignant pleuritis. The present study analyzes the mechanism of the effectiveness of this therapy by examining the induction ratio of apoptosis among tumor cells following the perfusion treatment.

METHODS: This study included 11 consecutive patients with primary pulmonary adenocarcinoma and accompanying pleural seedlings and pleural effusions containing tumor cells but without distant metastasis. All patients underwent surgical resection of the primary lesion and then received sequential perfusion treatment. Tumor cells collected from the effusion both before and again at 24 hours following the perfusion treatment were subsequently examined using an immunocytochemical stain to determine apoptosis among tumor cells. The percentage of positively stained cells was expressed as the apoptotic index. We compared the survival rate of these 11 patients with the survival rate of a second group of 11 patients with malignant pleuritis who underwent surgical resection of the primary lesion but who did not receive the perfusion treatment (control group).

RESULTS: The ratio of spontaneous apoptosis of untreated tumor cells was 2.8% ± 2.0%. Following the perfusion, apoptosis among tumor cells was 25.2% ± 4.6%, clearly a significant increase. While the median survival time for patients receiving the perfusion treatment was 20 months, the median survival time for the control group was 6 months.

CONCLUSIONS: In patients with malignant pleuritis, intrapleural hyperthermic perfusion with chemotherapy induced potent apoptosis of tumor cells in the pleural cavity and also improved the survival rate of these patients as compared with patients who did not receive the perfusion treatment.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.